Ball & Co Wealth Management »

Summit Therapeutics shares owned by Ball & Co Wealth Management

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Ball & Co Wealth Management from 13F filings

Historical chart of Ball & Co Wealth Management investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Ball & Co Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Ball & Co Wealth Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $28k 1.5k 18.67
2025-09-30 $30k 1.5k 20.00
2025-06-30 $31k 1.5k 20.67

More positions owned by Ball & Co Wealth Management

Vanguard Specialized Funds Div App Etf (VIG)
Ishares Tr Eafe Value Etf (EFV)
Ishares Tr Rus 1000 Grw Etf (IWF)
Spdr Gold Tr Gold Shs (GLD)
Kraneshares Trust Hedgeye Hedged E (KSPY)
Capital Group Dividend Value Shs Creation Uni (CGDV)
Alps Etf Tr Alerian Mlp (AMLP)
Amgen (AMGN)
Invesco Actvely Mngd Etc Optimum Yield (PDBC)
Fidelity Covington Trust Enhanced Large (FELG)
Gilead Sciences (GILD)
Apple (AAPL)
Fidelity Covington Trust Enhanced Large (FELV)
Fidelity Covington Trust Enhanced Intl (FENI)
Abbvie (ABBV)

View all positions for Ball & Co Wealth Management

Top funds holding Summit Therapeutics

Baker Bros. Advisors
FMR
Vanguard Group
BlackRock
State Street Corporation
Vanguard Capital Management
Vanguard Portfolio Management
UBS Group
Geode Capital Management
Susquehanna International
D. E. Shaw & Co
Morgan Stanley
Pictet Asset Management Holding SA
Apeiron Capital
Citadel Advisors

View all funds holding Summit Therapeutics